Moderator: Carlos Torres

The Critical Role of Imaging in Alzheimer’s and ARIA Diagnosis
Manish Joshi

The goal of this symposium is to provide delegates with an in-depth learning opportunity in the field of neuroradiology. Delegates will learn about the critical role of imaging in the diagnosis of Alzheimer's disease and amyloid-related imaging abnormalities (ARIA), a common side effect of new anti-amyloid therapies. Magnetic Resonance Imaging (MRI) is the central tool for monitoring ARIA, allowing clinicians to manage treatment safely. This symposium will discuss the recent evidence on ARIA, guidance from leading experts, as well as resources and management tools to support implementation of new disease modifying treatments in Canadian practices.

At the end of this symposium, delegates will be able to:

• Describe the current diagnostic criteria for Alzheimer’s Disease and summarize updates on treatment options available in Canada.
• Identify and report Amyloid-Related Imaging Abnormalities (ARIA) to ensure appropriate patient safety management.
• Analyze strategies for real-world implementation of Alzheimer’s therapies and propose approaches to build capacity within clinical settings.

CanMEDS:

• Medical Expert
• Scholar
• Professional
• Leader
• Collaborator
• Health Advocate

Target Audience:

• Practicing Radiologists
• Fellows & Residents

COI: Dr. Manish Joshi has received financial payments as a consultant neuroradiologist and speaker for Eisai Canada, Eli Lilly Canada, Biogen Canada, Clario, Circle Cardiovascular, and GE Health. Additionally, he has participated in funded grants and trials as a co-investigator and collaborator with the Canadian Institutes of Health Research (CIHR) and the MS Society of Canada.